1. Home
  2. NVCR vs BBUC Comparison

NVCR vs BBUC Comparison

Compare NVCR & BBUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • BBUC
  • Stock Information
  • Founded
  • NVCR 2000
  • BBUC 2022
  • Country
  • NVCR Switzerland
  • BBUC United States
  • Employees
  • NVCR N/A
  • BBUC N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • BBUC
  • Sector
  • NVCR Health Care
  • BBUC
  • Exchange
  • NVCR Nasdaq
  • BBUC Nasdaq
  • Market Cap
  • NVCR 1.9B
  • BBUC 1.7B
  • IPO Year
  • NVCR 2015
  • BBUC N/A
  • Fundamental
  • Price
  • NVCR $19.11
  • BBUC $28.53
  • Analyst Decision
  • NVCR Buy
  • BBUC
  • Analyst Count
  • NVCR 6
  • BBUC 0
  • Target Price
  • NVCR $32.83
  • BBUC N/A
  • AVG Volume (30 Days)
  • NVCR 941.3K
  • BBUC 80.9K
  • Earning Date
  • NVCR 07-24-2025
  • BBUC 01-01-0001
  • Dividend Yield
  • NVCR N/A
  • BBUC 0.88%
  • EPS Growth
  • NVCR N/A
  • BBUC N/A
  • EPS
  • NVCR N/A
  • BBUC N/A
  • Revenue
  • NVCR $621,711,000.00
  • BBUC $8,309,000,000.00
  • Revenue This Year
  • NVCR $5.56
  • BBUC N/A
  • Revenue Next Year
  • NVCR $9.15
  • BBUC N/A
  • P/E Ratio
  • NVCR N/A
  • BBUC N/A
  • Revenue Growth
  • NVCR 18.27
  • BBUC 8.15
  • 52 Week Low
  • NVCR $14.17
  • BBUC $18.21
  • 52 Week High
  • NVCR $34.13
  • BBUC $30.00
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 58.46
  • BBUC 57.22
  • Support Level
  • NVCR $18.66
  • BBUC $27.64
  • Resistance Level
  • NVCR $20.06
  • BBUC $28.83
  • Average True Range (ATR)
  • NVCR 0.86
  • BBUC 0.76
  • MACD
  • NVCR 0.19
  • BBUC -0.13
  • Stochastic Oscillator
  • NVCR 71.98
  • BBUC 37.71

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About BBUC Brookfield Business Corporation Exchangeable Subordinate Voting Shares

Brookfield Business Corp is a company established as a vehicle that owns and operates certain services and industrial operations on a world-wide basis and an alternative vehicle for investors who prefer investing in its operations through a corporate structure. Its goal is to generate returns through long-term capital appreciation with a modest distribution yield.

Share on Social Networks: